<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04221581</url>
  </required_header>
  <id_info>
    <org_study_id>2018-38</org_study_id>
    <nct_id>NCT04221581</nct_id>
  </id_info>
  <brief_title>Study Conducted on Patients Operated With a FHK ASYMETRIQUE to Confirm Security and Performance of the Device</brief_title>
  <official_title>Prospective Observational Clinical Study Conducted on Patient Operated With a Total Knee Prosthesis FHK ASYMETRIQUE to Confirm Security and Performance of the Device Over a Period of 10 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FH Orthopedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FH Orthopedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a post-market clinical follow-up conducted in order to collect long-term data
      on security and performance of the FHK asymetrique prosthesis, which is intended to be
      implanted in case of total knee replacement, when used in real life conditions according to
      the instructions for use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to evaluate the security of the FHK ASYMETRIQUE
      prosthesis by calculating the survival rate up to 10 years of follow-up.

      The secondary objectives are to evaluate the security and performance of the device by
      assessing radiological data, gathering complications and evaluating functional score up to 10
      years of follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 20, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2031</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2031</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate</measure>
    <time_frame>10 years post-op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiological evaluation</measure>
    <time_frame>preoperative, 3 months post-op, 1 year post-op, 3 years post-op, 5 years post-op, 10 years post-op</time_frame>
    <description>Radiological results such as stability, osteointegration will be evaluated. The HKA angle will be mesurated. It is the angle (in degrees) between the center of the femoral head, the center of the knee and the center of the tibio-fibluar mortise. This radiological evaluation is a usual assessment used in the follow-up of patients operated for a total knee replacement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of complications</measure>
    <time_frame>peroperative, 3 months postoperative, 1 year post-op, 3 years post-op, 5 years post-op, 10 years post-op</time_frame>
    <description>All complications will be gathered during intervention and up to 10 years postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcomes such as pain, mobility.</measure>
    <time_frame>preoperative, 3 months post-op, 1 year post-op, 3 years post-op, 5 years post-op, 10 years post-op</time_frame>
    <description>Functional outcomes will be determined by the IKS score. New IKS score range from 0 to 200 with a physical score on 100 points (pain, knee's mobility, abnormal laxity, flexion deformity and Hips knee Ankle) and a functional score on 100 points (walking distance, difficulty with stairs and use of walking aids).</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">173</enrollment>
  <condition>Knee Disease</condition>
  <arm_group>
    <arm_group_label>Patients receiving FHK ASYMETRIQUE prosthesis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Knee prosthesis - FHK ASYMETRIQUE total knee prosthesis</intervention_name>
    <description>FHK ASYMETRIQUE prosthesis are intended to be implanted in the tibial and femoral regions during total knee arthroplasty in order to restore joint function.</description>
    <arm_group_label>Patients receiving FHK ASYMETRIQUE prosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from participating hospitals will be enrolled as part of their clinical routine
        care
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults subjects (≥18 years old).

          -  Subject implanted with FHK ASYMETRIQUE prosthesis in one of the following indication
             according to the instructions for use: knee disorders; Aseptic condylar necrosis.

          -  Subject who received an information form and is willing to participate in the study.

        Exclusion Criteria:

          -  Contraindications described in the instructions for use

          -  Usual surgical contraindications

          -  Patients objecting to participate in this study

          -  Subject who is not able to express his/her non-opposition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clinical Project Manager</last_name>
    <phone>+33389818944</phone>
    <email>w.vandenberghe@groupe-fh.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique de la Miotte</name>
      <address>
        <city>Belfort</city>
        <zip>90000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du cèdre</name>
      <address>
        <city>Bois-Guillaume</city>
        <zip>76230</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Médipôle Saint-Roch</name>
      <address>
        <city>Cabestany</city>
        <zip>66330</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Haut Anjou</name>
      <address>
        <city>Château-Gontier</city>
        <zip>53200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Pasteur</name>
      <address>
        <city>Colmar</city>
        <zip>68000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Sainte Odile</name>
      <address>
        <city>Haguenau</city>
        <zip>67501</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste de la Porte de l'Orient</name>
      <address>
        <city>Lorient</city>
        <zip>56324</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre chirurgical Emile Gallé</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Hôpital Nord</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Médipôle Garonne</name>
      <address>
        <city>Toulouse</city>
        <zip>31036</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 18, 2019</study_first_submitted>
  <study_first_submitted_qc>January 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2020</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee</keyword>
  <keyword>Arthroplasty</keyword>
  <keyword>Replacement</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

